0 Yorumlar
0 hisse senetleri
206 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
From Conventional to Targeted: Tracing the Pivotal Shift in Soft Tissue Sarcoma Treatment Modalities and Drug Pipeline DynamicsHistorically, the treatment paradigm for soft tissue sarcoma (STS) relied heavily on a combination of surgical resection, radiation therapy, and cytotoxic chemotherapy, the latter often serving as the primary systemic treatment for advanced or metastatic disease. While chemotherapy drugs like doxorubicin and ifosfamide remain foundational, their non-specific mechanism of action often leads to...0 Yorumlar 0 hisse senetleri 314 Views 0 önizleme
-
Quantifying Market Size by Drug Volume and Revenue: The Commercial Valuation of Acid Suppressants in the Germany Gastritis Treatment MarketQuantifying the market Size of the Germany Gastritis Treatment Market involves assessing the massive procedural and prescription volume generated by the core drug classes, primarily Proton Pump Inhibitors (PPIs). The total market Size is directly correlated with the high prevalence of gastritis and ulcer disease in the general German population, a figure that is consistently translated...0 Yorumlar 0 hisse senetleri 199 Views 0 önizleme
-
Amitriptyline Market: Projected to Hit $1.01 Billion by 2032Introspective Market Research (IMR) today released its comprehensive report on the Global Amitriptyline Market. According to the analysis, the market was valued at USD 609.2 million in 2023 and is projected to reach USD 1,011.9 million by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2032. This growth is largely underpinned by the expanding burden of depression and...0 Yorumlar 0 hisse senetleri 547 Views 0 önizleme
-
ANTIPSYCHOTIC DRUGS MARKET: Global Value Set to Double, Reaching $33.91 Billion by 2032Introspective Market Research (IMR) today published a new report on the Global Antipsychotic Drugs Market, forecasting it to grow from USD 17.48 billion in 2023 to USD 33.91 billion by 2032, at a compound annual growth rate (CAGR) of 7.63% over the 2024–2032 period. This expansion is largely driven by increasing global incidence of psychiatric disorders such as schizophrenia and bipolar...0 Yorumlar 0 hisse senetleri 394 Views 0 önizleme
-
Onychomycosis Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) announces the publication of its latest in-depth analysis of the Global Onychomycosis Treatment Market. Onychomycosis, a common fungal infection affecting fingernails and toenails, is demanding increasingly sophisticated and rapid treatment modalities. The market, which was valued at USD 3.5 Billion in 2023, is projected to grow to USD 5.2 Billion by 2032,...0 Yorumlar 0 hisse senetleri 220 Views 0 önizleme
-
Orthopaedic Devices MarketIntrospective Market Research (IMR) has released a definitive analysis of the Global Orthopaedic Devices Market, revealing a landscape rapidly being reshaped by digital surgery and patient-specific implant design. The market, valued at USD 60.5 Billion in 2023, is forecast to achieve a valuation of USD 89.14 Billion by the end of 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of...0 Yorumlar 0 hisse senetleri 296 Views 0 önizleme
-
Osteoarthritis Drugs MarketIntrospective Market Research (IMR) today unveiled a critical new report detailing the accelerated evolution of the Global Osteoarthritis (OA) Drugs Market. The market, valued at USD 4.70 Billion in 2023, is forecast to more than double, reaching USD 10.38 Billion by 2032, demonstrating a high-velocity Compound Annual Growth Rate (CAGR) of 9.2% during the 2024–2032 forecast period. This...0 Yorumlar 0 hisse senetleri 261 Views 0 önizleme
-
Respiratory Tract Infection Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) has released a critical analysis of the Global Respiratory Tract Infection (RTI) Treatment Market, highlighting its rapid expansion fueled by persistent global health challenges. RTIs, including pneumonia, bronchitis, and sinusitis, remain a leading cause of morbidity and mortality worldwide. The market, which was valued at USD 40.20 Billion in 2023, is...0 Yorumlar 0 hisse senetleri 298 Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
